{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:07:29Z","timestamp":1778638049113,"version":"3.51.4"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.mehy.2019.109326","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T06:10:18Z","timestamp":1563948618000},"page":"109326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia"],"prefix":"10.1016","volume":"132","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Iloki-Assanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidianys Maria Lewis","family":"Lujany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0010","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41598-017-02347-2","article-title":"Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0015","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/s41598-018-36626-3","article-title":"Toll-Like receptor-4 disruption suppresses adipose tissue remodeling and increases survival in cancer cachexia syndrome","volume":"8","author":"Henriques","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0020","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","article-title":"Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia","volume":"391","author":"Benny Klimek","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.mehy.2019.109326_b0025","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/0008-5472.CAN-14-0057","article-title":"Myostatin gene inactivation prevents skeletal muscle wasting in cancer","volume":"74","author":"Gallot","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2019.109326_b0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-016-0098-2","article-title":"ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments","volume":"6","author":"Hatakeyama","year":"2016","journal-title":"Skelet Muscle"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-019-0193-2","article-title":"IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Skelet Muscle"},{"issue":"7","key":"10.1016\/j.mehy.2019.109326_b0040","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2006-1500","article-title":"Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression","volume":"148","author":"Durieux","year":"2007","journal-title":"Endocrinology"},{"issue":"5572","key":"10.1016\/j.mehy.2019.109326_b0045","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0050","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2014-4318","article-title":"Role of activin A and myostatin in human cancer cachexia","volume":"100","author":"de Loumaye","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Pt B","key":"10.1016\/j.mehy.2019.109326_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.canlet.2014.10.037","article-title":"Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer","volume":"356","author":"Togashi","year":"2015","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2044-5040-2-20","article-title":"p38beta MAPK upregulates atrogin1\/MAFbx by specific phosphorylation of C\/EBPbeta","volume":"2","author":"Zhang","year":"2012","journal-title":"Skelet Muscle"},{"issue":"7","key":"10.1016\/j.mehy.2019.109326_b0065","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1096\/fj.12-222711","article-title":"Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2","volume":"27","author":"Zhang","year":"2013","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0075","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ni1200","article-title":"ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity","volume":"6","author":"Matsuzawa","year":"2005","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.mehy.2019.109326_b0080","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/emboj\/17.9.2596","article-title":"Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1","volume":"17","author":"Saitoh","year":"1998","journal-title":"EMBO J"},{"issue":"23","key":"10.1016\/j.mehy.2019.109326_b0085","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1128\/MCB.00227-07","article-title":"Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1","volume":"27","author":"Fujino","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"5296","key":"10.1016\/j.mehy.2019.109326_b0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.275.5296.90","article-title":"Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways","volume":"275","author":"Ichijo","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/MCB.26.1.140-154.2006","article-title":"Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes","volume":"26","author":"Li","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"22","key":"10.1016\/j.mehy.2019.109326_b0100","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1101\/gad.1360605","article-title":"TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo","volume":"19","author":"Shim","year":"2005","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/jmf.2007.621","article-title":"Clinical potential of Spirulina as a source of phycocyanobilin","volume":"10","author":"McCarty","year":"2007","journal-title":"J Med Food"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0110","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1152\/ajpregu.00648.2011","article-title":"Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress","volume":"304","author":"Zheng","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2019.109326_b0115","first-page":"56","article-title":"Preclinical Studies Suggest Complex Nutraceutical Strategies May Have Potential for Preventing and Managing Sepsis","volume":"21","author":"McCarty","year":"2015","journal-title":"Altern Ther Health Med"},{"key":"10.1016\/j.mehy.2019.109326_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mehy.2018.06.032","article-title":"Ferulic acid may target MyD88-mediated pro-inflammatory signaling - Implications for the health protection afforded by whole grains, anthocyanins, and coffee","volume":"118","author":"McCarty","year":"2018","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0125","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3892\/ijmm.2017.3127","article-title":"Ferulic acid exerts neuroprotective effects against cerebral ischemia\/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivo","volume":"40","author":"Ren","year":"2017","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2019.109326_b0135","doi-asserted-by":"crossref","first-page":"942","DOI":"10.5604\/01.3001.0010.5809","article-title":"GPR120: Mechanism of action, role and potential for medical applications","volume":"71","author":"Karakula-Juchnowicz","year":"2017","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040432","article-title":"Obesity, Inflammation, toll-like receptor 4 and fatty acids","volume":"10","author":"Rogero","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"N-3 fatty acids, cancer and cachexia: a systematic review of the literature","volume":"97","author":"Colomer","year":"2007","journal-title":"Br J Nutr"},{"key":"10.1016\/j.mehy.2019.109326_b0150","article-title":"New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids","author":"Gorjao","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2005.05.108","article-title":"Epigallocatechin-3-O-gallate disrupts stress fibers and the contractile ring by reducing myosin regulatory light chain phosphorylation mediated through the target molecule 67 kDa laminin receptor","volume":"333","author":"Umeda","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2007.09.095","article-title":"The 67kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG","volume":"364","author":"Fujimura","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4049\/jimmunol.0903742","article-title":"TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor","volume":"185","author":"Hong","year":"2010","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbrc.2012.08.096","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells","volume":"426","author":"Byun","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.mehy.2019.109326_b0175","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.imbio.2014.07.010","article-title":"Epigallocatechin-3-gallate-mediated Tollip induction through the 67-kDa laminin receptor negatively regulating TLR4 signaling in endothelial cells","volume":"219","author":"Byun","year":"2014","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0180","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1021\/jf505531w","article-title":"Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes","volume":"63","author":"Bao","year":"2015","journal-title":"J Agric Food Chem"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0185","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.M116.755959","article-title":"Green Tea polyphenol epigallocatechin-3-gallate suppresses toll-like receptor 4 expression via up-regulation of E3 ubiquitin-protein Ligase RNF216","volume":"292","author":"Kumazoe","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2019.109326_b0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.intimp.2017.08.023","article-title":"Epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor and effectively alleviates acute lung injury induced by H9N2 swine influenza virus","volume":"52","author":"Xu","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0195","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1159\/000481643","article-title":"Epigallocatechin-3-gallate inhibits matrix metalloproteinase-9 and monocyte chemotactic protein-1 expression through the 67-kappada laminin receptor and the TLR4\/MAPK\/NF-kappaB signalling pathway in lipopolysaccharide-induced macrophages","volume":"43","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0200","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1248\/bpb.b13-00349","article-title":"Comparison of (-)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats","volume":"36","author":"Oritani","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.mehy.2019.109326_b0205","article-title":"Chemistry and health effect of tea polyphenol (-)-epigallocatechin 3- O-(3- O-Methyl)gallate","volume":"22","author":"Zhang","year":"2018","journal-title":"J Agric Food Chem"},{"issue":"9","key":"10.1016\/j.mehy.2019.109326_b0210","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.4049\/jimmunol.1601822","article-title":"Green tea polyphenol EGCG upregulates tollip expression by suppressing Elf-1 expression","volume":"199","author":"Kumazoe","year":"2017","journal-title":"J Immunol"},{"issue":"4552","key":"10.1016\/j.mehy.2019.109326_b0215","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1126\/science.6123152","article-title":"Biotin enhances guanylate cyclase activity","volume":"216","author":"Vesely","year":"1982","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0220","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00222480","article-title":"Biotin analogs activate guanylate cyclase","volume":"60","author":"Vesely","year":"1984","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0225","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/S0021-9258(20)82154-1","article-title":"Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes","volume":"259","author":"Spence","year":"1984","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0230","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S0007114507841122","article-title":"Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats","volume":"99","author":"Watanabe-Kamiyama","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.mehy.2019.109326_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mehy.2017.10.012","article-title":"Neuroprotective potential of high-dose biotin","volume":"109","author":"McCarty","year":"2017","journal-title":"Med Hypotheses"},{"issue":"13","key":"10.1016\/j.mehy.2019.109326_b0240","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1177\/1352458516667568","article-title":"MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study","volume":"22","author":"Tourbah","year":"2016","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00075197-200303000-00013","article-title":"L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent","volume":"6","author":"Zhong","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.mehy.2019.109326_b0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mehy.2019.01.012","article-title":"Activated glycine receptors may decrease endosomal NADPH oxidase activity by opposing ClC-3-mediated efflux of chloride from endosomes","volume":"123","author":"McCarty","year":"2019","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.mehy.2019.109326_b0255","first-page":"574","article-title":"The protection mechanisms of glycine against liver injury induced by lipopolysaccharides","volume":"14","author":"You","year":"2006","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.amjsurg.2007.09.045","article-title":"Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells","volume":"196","author":"Xu","year":"2008","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0265","doi-asserted-by":"crossref","first-page":"R365","DOI":"10.1152\/ajpregu.00043.2016","article-title":"Glycine enhances muscle protein mass associated with maintaining Akt-mTOR-FOXO1 signaling and suppressing TLR4 and NOD2 signaling in piglets challenged with LPS","volume":"311","author":"Liu","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0270","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clnu.2013.06.013","article-title":"Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia","volume":"33","author":"Ham","year":"2014","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MCO.0000000000000383","article-title":"Glycine metabolism in skeletal muscle: implications for metabolic homeostasis","volume":"20","author":"Koopman","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"10.1016\/j.mehy.2019.109326_b0280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nutres.2008.04.006","article-title":"Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression","volume":"28","author":"Nunes","year":"2008","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0285","first-page":"713","article-title":"beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia","volume":"38","author":"Aversa","year":"2011","journal-title":"Int J Oncol"},{"issue":"7\u20138","key":"10.1016\/j.mehy.2019.109326_b0290","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.nut.2013.11.012","article-title":"Comparison of the anticatabolic effects of leucine and Ca-beta-hydroxy-beta-methylbutyrate in experimental models of cancer cachexia","volume":"30","author":"Mirza","year":"2014","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0295","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13105-010-0037-3","article-title":"Effects of beta-hydroxy-beta-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats","volume":"66","author":"Kovarik","year":"2010","journal-title":"J Physiol Biochem"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/0008-5472.277.65.1","article-title":"Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss","volume":"65","author":"Smith","year":"2005","journal-title":"Cancer Res"},{"issue":"196","key":"10.1016\/j.mehy.2019.109326_b0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.resp.2014.02.015","article-title":"beta-hydroxy-beta-methylbutyrate (HMB) prevents sepsis-induced diaphragm dysfunction in mice","volume":"1","author":"Supinski","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0310","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9610(02)00823-1","article-title":"Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine","volume":"183","author":"May","year":"2002","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0315","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00520-008-0403-7","article-title":"A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)","volume":"16","author":"Berk","year":"2008","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcsm.12127","article-title":"A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project","volume":"8","author":"Mochamat","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.mehy.2019.109326_b0325","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni0901-835","article-title":"TIRAP: an adapter molecule in the Toll signaling pathway","volume":"2","author":"Horng","year":"2001","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0330","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1152\/ajpendo.90530.2008","article-title":"Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate","volume":"295","author":"Eley","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"45","key":"10.1016\/j.mehy.2019.109326_b0335","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","article-title":"PKR; a sentinel kinase for cellular stress","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0340","doi-asserted-by":"crossref","first-page":"E923","DOI":"10.1152\/ajpendo.00314.2007","article-title":"Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli","volume":"293","author":"Eley","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2019.109326_b0345","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11010-009-0130-5","article-title":"Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide","volume":"330","author":"Russell","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0350","doi-asserted-by":"crossref","first-page":"E1417","DOI":"10.1152\/ajpendo.90567.2008","article-title":"Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate","volume":"295","author":"Eley","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2019.109326_b0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/nu10020206","article-title":"A ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice","volume":"10","author":"Nakamura","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0365","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tem.2019.01.006","article-title":"Anticatabolic effects of ketone bodies in skeletal muscle","volume":"30","author":"Koutnik","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2014.08.009","article-title":"beta-hydroxybutyrate: much more than a metabolite","volume":"106","author":"Newman","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0375","first-page":"126","article-title":"Screening of different organs of rats for HCA2 receptor mRNA","volume":"3","author":"Shomali","year":"2014","journal-title":"Int J Mol Cell Med"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0380","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.3168\/jds.2011-4193","article-title":"An unusual distribution of the niacin receptor in cattle","volume":"94","author":"Titgemeyer","year":"2011","journal-title":"J Dairy Sci"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","article-title":"Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0390","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI36806","article-title":"beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice","volume":"119","author":"Walters","year":"2009","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.mehy.2019.109326_b0395","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1113\/JP273185","article-title":"Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation","volume":"595","author":"Evans","year":"2017","journal-title":"J Physiol"},{"issue":"12","key":"10.1016\/j.mehy.2019.109326_b0400","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0405","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(01)02815-0","article-title":"Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia?","volume":"505","author":"Busquets","year":"2001","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0410","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0261-5614(89)90010-1","article-title":"Muscle carnitine pools in cancer patients","volume":"8","author":"Rossle","year":"1989","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0415","first-page":"319","article-title":"L-carnitine and cancer cachexia. I. L-carnitine distribution and metabolic disorders in cancer cachexia","volume":"28","author":"Szefel","year":"2012","journal-title":"Oncol Rep"},{"issue":"32","key":"10.1016\/j.mehy.2019.109326_b0420","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"273","author":"Tamai","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0425","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/cbt.12.2.15717","article-title":"L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase","volume":"12","author":"Liu","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0430","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.clnu.2012.03.005","article-title":"L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer","volume":"31","author":"Busquets","year":"2012","journal-title":"Clin Nutr"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0435","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/07357907.2011.626476","article-title":"Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats","volume":"29","author":"Laviano","year":"2011","journal-title":"Cancer Invest"},{"issue":"11","key":"10.1016\/j.mehy.2019.109326_b0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)\u2013a randomized multicentre trial","volume":"23","author":"Kraft","year":"2012","journal-title":"Nutr J"},{"issue":"31","key":"10.1016\/j.mehy.2019.109326_b0445","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2011.40.2180","article-title":"L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial","volume":"30","author":"Cruciani","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0450","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00002512-200320100-00004","article-title":"Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue","volume":"20","author":"Pistone","year":"2003","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.smj.0000203331.26947.47","article-title":"L-carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly","volume":"99","author":"Malaguarnera","year":"2006","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0460","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/ajcn\/86.5.1738","article-title":"L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial","volume":"86","author":"Malaguarnera","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.mehy.2019.109326_b0465","article-title":"L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS ONE"},{"issue":"Pt 7","key":"10.1016\/j.mehy.2019.109326_b0470","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1242\/jcs.136390","article-title":"HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy","volume":"127","author":"Beharry","year":"2014","journal-title":"J Cell Sci"},{"issue":"12","key":"10.1016\/j.mehy.2019.109326_b0475","doi-asserted-by":"crossref","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical Investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0480","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543784.2019.1557634","article-title":"New developments in investigational HDAC inhibitors for the potential multimodal treatment of cachexia","volume":"28","author":"Penna","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0485","doi-asserted-by":"crossref","first-page":"C101","DOI":"10.1152\/ajpcell.00344.2015","article-title":"Valproic acid attenuates skeletal muscle wasting by inhibiting C\/EBPbeta-regulated atrogin1 expression in cancer cachexia","volume":"311","author":"Sun","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0490","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"Fessler","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0495","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/dc11-2375","article-title":"Increased toll-like receptor activity in patients with metabolic syndrome","volume":"35","author":"Jialal","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0500","doi-asserted-by":"crossref","first-page":"G270","DOI":"10.1152\/ajpgi.00304.2014","article-title":"Hepatic TLR4 signaling in obese NAFLD","volume":"309","author":"Sharifnia","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0505","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1523\/JNEUROSCI.2760-08.2009","article-title":"Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity","volume":"29","author":"Milanski","year":"2009","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nutres.2013.03.006","article-title":"Phycocyanin prevents hypertension and low serum adiponectin level in a rat model of metabolic syndrome","volume":"33","author":"Ichimura","year":"2013","journal-title":"Nutr Res"},{"issue":"9","key":"10.1016\/j.mehy.2019.109326_b0515","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.dld.2012.02.002","article-title":"Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"13","key":"10.1016\/j.mehy.2019.109326_b0520","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1476-511X-13-191","article-title":"Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naive patients in Yaounde-Cameroon: a randomized trial study","volume":"13","author":"Ngo-Matip","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.mehy.2019.109326_b0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ctim.2018.08.003","article-title":"Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: a randomized controlled trial","volume":"40","author":"Yousefi","year":"2018","journal-title":"Complement Ther Med"},{"issue":"254","key":"10.1016\/j.mehy.2019.109326_b0530","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cbi.2016.06.013","article-title":"Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: Effect on endothelial-dependent relaxation","volume":"25","author":"El-Bassossy","year":"2016","journal-title":"Chem Biol Interact"},{"issue":"8","key":"10.1016\/j.mehy.2019.109326_b0535","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.3390\/nu7085283","article-title":"Ferulic acid alleviates changes in a rat model of metabolic syndrome induced by high-carbohydrate, High-Fat Diet","volume":"7","author":"Senaphan","year":"2015","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0540","article-title":"Effects of ferulic acid and gamma-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0545","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060713","article-title":"Ferulic acid supplementation improves lipid profiles, oxidative stress, and inflammatory status in hyperlipidemic subjects: a randomized, double-blind, placebo-controlled clinical trial","volume":"10","author":"Bumrungpert","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0550","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1139\/cjpp-2012-0341","article-title":"Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure","volume":"91","author":"Diaz-Flores","year":"2013","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2019.109326_b0555","doi-asserted-by":"crossref","first-page":"2101562","DOI":"10.1155\/2018\/2101562","article-title":"Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance","volume":"2018","author":"El-Hafidi","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"49","key":"10.1016\/j.mehy.2019.109326_b0560","doi-asserted-by":"crossref","first-page":"80223","DOI":"10.18632\/oncotarget.12831","article-title":"Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2019.109326_b0565","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.nutres.2018.06.007","article-title":"Protective effect of supplementation with biotin against high-fructose-induced metabolic syndrome in rats","volume":"57","author":"Aguilera-Mendez","year":"2018","journal-title":"Nutr Res"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0570","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/biof.1034","article-title":"The hypotriglyceridemic effect of biotin supplementation involves increased levels of cGMP and AMPK activation","volume":"38","author":"Aguilera-Mendez","year":"2012","journal-title":"BioFactors"},{"issue":"4","key":"10.1016\/j.mehy.2019.109326_b0575","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biopha.2006.03.005","article-title":"Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia","volume":"60","author":"Revilla-Monsalve","year":"2006","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0580","doi-asserted-by":"crossref","first-page":"E1378","DOI":"10.1152\/ajpendo.00698.2006","article-title":"EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I\/R injury in SHR","volume":"292","author":"Potenza","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2019.109326_b0585","first-page":"273","article-title":"Multifunctional effects of green tea catechins on prevention of the metabolic syndrome","volume":"17","author":"Ikeda","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/07315724.2010.10719814","article-title":"Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome","volume":"29","author":"Basu","year":"2010","journal-title":"J Am Coll Nutr"},{"issue":"21","key":"10.1016\/j.mehy.2019.109326_b0595","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1021\/jf2029016","article-title":"Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat\/Western-style diet-induced obesity and metabolic syndrome in mice","volume":"59","author":"Chen","year":"2011","journal-title":"J Agric Food Chem"},{"issue":"7","key":"10.1016\/j.mehy.2019.109326_b0600","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.3390\/nu7075230","article-title":"Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome","volume":"7","author":"Legeay","year":"2015","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0605","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.bbadis.2017.04.009","article-title":"EGCG ameliorates diet-induced metabolic syndrome associating with the circadian clock","volume":"1863","author":"Mi","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"10.1016\/j.mehy.2019.109326_b0610","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101689","article-title":"Role of n-3 polyunsaturated fatty acids in ameliorating the obesity-induced metabolic syndrome in animal models and humans","volume":"17","author":"Huang","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0615","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12944-017-0528-0","article-title":"Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis","volume":"16","author":"Gao","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"7","key":"10.1016\/j.mehy.2019.109326_b0620","doi-asserted-by":"crossref","DOI":"10.3390\/nu9070703","article-title":"n-3 polyunsaturated fatty acids and metabolic syndrome risk: a meta-analysis","volume":"9","author":"Guo","year":"2017","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.mehy.2019.109326_b0625","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1017\/S0007114509389230","article-title":"Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats","volume":"102","author":"Mingorance","year":"2009","journal-title":"Br J Nutr"},{"issue":"8","key":"10.1016\/j.mehy.2019.109326_b0630","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.numecd.2014.03.007","article-title":"Carnitine therapy for the treatment of metabolic syndrome and cardiovascular disease: evidence and controversies","volume":"24","author":"Johri","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0635","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1111\/hepr.12720","article-title":"L-carnitine prevents metabolic steatohepatitis in obese diabetic KK-A(y) mice","volume":"47","author":"Kon","year":"2017","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0640","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/cen.13003","article-title":"Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"84","author":"Samimi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.mehy.2019.109326_b0645","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/carcin\/20.5.793","article-title":"Dietary glycine inhibits the growth of B16 melanoma tumors in mice","volume":"20","author":"Rose","year":"1999","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.mehy.2019.109326_b0650","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00726-016-2278-0","article-title":"Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells","volume":"48","author":"Bruns","year":"2016","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0655","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/cbt.2.2.280","article-title":"Dietary glycine inhibits angiogenesis during wound healing and tumor growth","volume":"2","author":"Amin","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0660","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.mehy.2006.12.065","article-title":"A two-phase strategy for treatment of oxidant-dependent cancers","volume":"69","author":"McCarty","year":"2007","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2019.109326_b0665","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1665-2681(19)30891-9","article-title":"Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds","volume":"13","author":"Konickova","year":"2014","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.mehy.2019.109326_b0670","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ejca.2009.04.026","article-title":"The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential","volume":"45","author":"Spencer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.mehy.2019.109326_b0675","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/or.2016.4804","article-title":"Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.mehy.2019.109326_b0680","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","article-title":"ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells","volume":"156","author":"Yang","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mehy.2019.109326_b0685","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","article-title":"Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719304554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719304554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T12:43:17Z","timestamp":1664023397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719304554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":137,"alternative-id":["S0306987719304554"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109326","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109326"}}